Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
0%
3-year Growth Rate
R
2/3
3-year Risk Analysis
O
0%
Outlook 12/24
W
N/A
Margin of safety
T
-100%
Analyst Price Target
H
DOWN
50-week EMA Trend
It is not possible to show the GROWTH analysis for a period of five years. Showing the analysis for a period of three years instead.
Company Info
EPS Growth 3Y
7,42%
Revenue growth 3Y
0,00%
Price growth 3Y
-52,88%
Market Cap
NT$1,86 B
Long-Term Debt
NT$0,00 B
Quarterly earnings
11/06/2026
Dividend
NT$1,08
Dividend Yield
4,00%
Industry
Country
Website
ISIN Number
G&E Herbal Biotechnology Price Chart (TWD)
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
There are currently no price targets available for this stock.
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
G&E Herbal Biotechnology
TPEX:4911
|
4,98% | -3,91% | 8,90% | 0,00% | 2/3 | 0,00% | 0,00% | -100,00% | DOWN |
